Semi-Annual Statement Of Income And Retained Earnings

Oncolys BioPharma Inc. - Filing #7727337

Concept	2017-01-01 to 2017-12-31	2017-01-01 to 2017-12-31	2017-01-01 to 2017-12-31	2017-01-01 to 2017-12-31	2017-01-01 to 2017-12-31	2017-01-01 to 2017-12-31	2017-01-01 to 2017-12-31	2017-01-01 to 2017-12-31	2016-01-01 to 2016-12-31	2016-01-01 to 2016-12-31	2016-01-01 to 2016-12-31	2016-01-01 to 2016-12-31	2016-01-01 to 2016-12-31	2016-01-01 to 2016-12-31	2016-01-01 to 2016-12-31	2016-01-01 to 2016-12-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)	—	—	-541,734,000 JPY	-438,213,000 JPY	—	-1,078,389,000 JPY	-536,655,000 JPY	-103,521,000 JPY	—	—	-861,311,000 JPY	-423,296,000 JPY	-438,014,000 JPY	-105,058,000 JPY	-318,238,000 JPY	—
Non-operating income
Non-operating income	—	—	—	—	—	3,920,000 JPY	—	—	—	—	5,833,000 JPY	—	—	—	—	—
Non-operating expenses
Non-operating expenses	—	—	—	—	—	12,716,000 JPY	—	—	—	—	8,763,000 JPY	—	—	—	—	—
Ordinary profit (loss)	—	—	—	—	—	-1,087,185,000 JPY	—	—	—	—	-864,241,000 JPY	—	—	—	—	—
Extraordinary income
Extraordinary income	—	—	—	—	—	JPY	—	—	—	—	120,000 JPY	—	—	—	—	—
Extraordinary losses
Extraordinary losses	—	—	—	—	—	JPY	—	—	—	—	64,223,000 JPY	—	—	—	—	—
Profit (loss) before income taxes	—	—	—	—	—	-1,087,185,000 JPY	—	—	—	—	-928,344,000 JPY	—	—	—	—	—
Income taxes - current	—	—	—	—	—	3,518,000 JPY	—	—	—	—	3,052,000 JPY	—	—	—	—	—
Profit (loss)	-1,090,703,000 JPY	-1,090,703,000 JPY	—	—	-1,090,703,000 JPY	-1,090,703,000 JPY	—	—	-931,397,000 JPY	-931,397,000 JPY	-931,397,000 JPY	—	—	—	—	-931,397,000 JPY